Tea in Health and Disease

Tea, made from the leaves of the Camellia senenisis plant, is the second most consumed beverage worldwide after water. Accumulating evidence from cellular, animal, epidemiological and clinical studies have linked tea consumption to various health benefits, such as chemoprevention of cancers, chronic...

Full description

Saved in:
Bibliographic Details
:
Year of Publication:2019
Language:English
Physical Description:1 electronic resource (222 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 03700nam-a2201045z--4500
001 993548069204498
005 20231214133347.0
006 m o d
007 cr|mn|---annan
008 202102s2019 xx |||||o ||| 0|eng d
020 |a 3-03897-987-2 
035 |a (CKB)4920000000094827 
035 |a (oapen)https://directory.doabooks.org/handle/20.500.12854/60503 
035 |a (EXLCZ)994920000000094827 
041 0 |a eng 
100 1 |a Dou, Q. Ping  |4 auth 
245 1 0 |a Tea in Health and Disease 
260 |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2019 
300 |a 1 electronic resource (222 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
520 |a Tea, made from the leaves of the Camellia senenisis plant, is the second most consumed beverage worldwide after water. Accumulating evidence from cellular, animal, epidemiological and clinical studies have linked tea consumption to various health benefits, such as chemoprevention of cancers, chronic inflammation, heart and liver diseases, diabetes, neurodegenerative diseases, etc. Although such health benefits have not been consistently observed in some intervention trials, positive results from clinical trials have provided direct evidence supporting the cancer-protective effect of green tea. In addition, numerous mechanisms of action have been suggested to contribute to tea’s disease-preventive effects. Furthermore, effects of the processing and storage of tea, as well as additives on tea’s properties have been investigated. 
546 |a English 
653 |a polyphenols 
653 |a cell cycle arrest and apoptosis 
653 |a neuroblastoma 
653 |a salivary ?-amylase activity 
653 |a cancer apoptosis 
653 |a yaupon holly 
653 |a bioaccessibility 
653 |a fracture 
653 |a p53 
653 |a tea 
653 |a Liubao tea 
653 |a BE(2)-C 
653 |a matrix metalloproteinase-1 (MMP-1) 
653 |a catechin 
653 |a renal stone 
653 |a oxalate 
653 |a protein expression 
653 |a 67LR 
653 |a Alzheimer's disease 
653 |a EGCG 
653 |a nutraceutical 
653 |a diseases 
653 |a anti-oxidant 
653 |a heme oxygenase-1 
653 |a polyphenol 
653 |a anxiety 
653 |a matcha 
653 |a ERCC1/XPF 
653 |a neuro-sphere 
653 |a tea consumption 
653 |a theanine 
653 |a Rosmarinic acid 
653 |a yerba mate 
653 |a hypercalciuria 
653 |a gene expression 
653 |a microbiota 
653 |a cohort study 
653 |a histone deacetylase 2 (HDAC2) 
653 |a guayusa 
653 |a nuclear factor erythroid 2-related factor 2 (Nrf2) 
653 |a DNA repair 
653 |a mRNA expression 
653 |a caffeine 
653 |a chemoprevention 
653 |a cisplatin 
653 |a 6-OH-11-O-hydroxyphenanthrene 
653 |a adrenal hypertrophy 
653 |a hepatic damage 
653 |a anti-photoaging 
653 |a cell death 
653 |a green tea 
653 |a kudingcha 
653 |a suberoylanilide hydroxamic acid (SAHA) 
653 |a epigallocatechin gallate (EGCG) 
653 |a stress-reduction 
653 |a calcium oxalate monohydrate 
653 |a Camellia sinensis 
653 |a chemoresistance 
653 |a tea polyphenols 
653 |a green tea polyphenols 
653 |a green tea catechins 
653 |a N-MYC 
653 |a cancer 
653 |a epigallocatechin-gallate (EGCG) 
653 |a Parkinson's disease 
776 |z 3-03897-986-4 
906 |a BOOK 
ADM |b 2023-12-15 05:51:29 Europe/Vienna  |f system  |c marc21  |a 2019-11-10 04:18:40 Europe/Vienna  |g false 
AVE |i DOAB Directory of Open Access Books  |P DOAB Directory of Open Access Books  |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338723310004498&Force_direct=true  |Z 5338723310004498  |b Available  |8 5338723310004498